Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012;7(3):24-30.

Comparison of Resistant and Susceptible Strains of Trichomons vaginalis to Metronidazole Using PCR Method

S Rabiee  1 , A Bazmani, M Matini, M Fallah
Affiliations

Comparison of Resistant and Susceptible Strains of Trichomons vaginalis to Metronidazole Using PCR Method

S Rabiee et al. Iran J Parasitol. 2012.

Abstract

Background: Metronidazole is drug of choice recommended by WHO for treatment of trichomoniasis, however, some reports claims drug resistance in Trichomonas vaginalis isolates recently. The objective of this study was to determine the minimum lethal concentration (MLC) of metronidazole in resistant and sensitive strains, as well as genetic patterns of these stains by PCR method.

Methods: From February 2006 to March 2007, in a cross sectional study, clinical and wet mount examination of vaginal smear along with culture were performed on 683 women attending to public and private outpatient clinics in Hamadan. Trichomoniasis marked based on major clinical symptoms. Diagnosis confirmed using wet mount microscopically and culture in Diamond medium. A serial concentration of metronidazole was provided and all isolated Trichomonas strains (resistant and sensitive) tested by standard method. Finally, all sensitive and resistant strains examined by PCR technique.

Results: Only 15/683, (2.2%) of patients clinically diagnosed trichomonal vaginitis were positive for T. vaginalis by wet smear and culture. The minimum lethal concentration (MLC) for clinically sensitive isolates was 25 µg/ml; however, this concentration for resistant isolates was 200 µg/ml after 24 h and 100 µg/ml after 50 h. The results of PCR examination of DNA from sensitive and resistant isolates had same pattern. The lanes appeared by two primers were 98 bp and 261 bp for both clinically sensitive and resistant strains.

Conclusion: Resistance to metronidazole in T. vaginalis has not relation to genetic variations and might be related to some physiologic pathways of organism.

Keywords: Metronidazole; PCR; Resistance; Trichomonas vaginalis.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Electrophoresis of PCR product from clinically resistant and susceptible isolates of T.vaginalis with TVK3 and TVK7 primers on agarose gel. Lane 1 (far left) 1-kb DNA ladder (size marker); lanes 3-4 sensitive isolates (261bp); lanes 8-10 clinically resistant isolates. The expected product size was 261-bp. The gel shows same pattern for both isolates
See this image and copyright information in PMC

References

    1. Meri T, Jokiranta TS, Suhonen L, Meri S. Resistance of Trichomonas vaginalis to metronidazole: report of the first three cases from Finland and optimization of in vitro susceptibility testing under various oxygen concentrations. J Clin Microbiol. 2000;38(2):763–7. - PMC - PubMed
    1. Snipes LJ, Gamard PM, Narcisi EM, Beard CB, Lehmann T, Secor WE. Molecular epidemiology of metronidazole resistance in a population of Trichomonas vaginalis clinical isolates. J Clin Microbiol. 2000;38(8):3004–3009. - PMC - PubMed
    1. Johanson S, Sanchez JL, Gerding DN. Metronidazole resistance in Clostridium difficile . Clin Infect Dis. 2000;31:625–6. - PubMed
    1. Löfmark S, Edlund C, Nord CE. Metronidazole is still the drug of choice for treatment of anaerobic infections. Clin Infect Dis. 2010;1(50 Suppl 1):S16–23. - PubMed
    1. Schmidt G, Narcici E, Mosure D, Secor WE, Higgins J, Moreno H. Prevalence of metronidazole resistant Trichomonas vaginalis in a gynecology clinic. J Reprod Med. 2001;46:545–549. - PubMed

LinkOut - more resources